World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
99
Citations
45818
World Ranking
8468
National Ranking
828

Overview

Helen M. Colhoun is affiliated with the University of Edinburgh in the United Kingdom. Their primary field of study is Medicine, with a specific focus on Endocrinology, Diabetes and Metabolism, Genetics, Molecular Biology, Surgery, and Infectious Diseases. Their research spans several key topics including Diabetes Treatment and Management, Diabetes Management and Research, Metabolism, Diabetes and Cancer, Diabetes and associated disorders, COVID-19 Clinical Research Studies, Pancreatic function and diabetes, and Pharmacology and Obesity Treatment.

They have contributed to numerous publications in various scientific venues, with frequent contributions in Diabetes Care, bioRxiv (Cold Spring Harbor Laboratory), Diabetologia, Diabetes, and The Lancet Diabetes & Endocrinology. The volume of work in these venues highlights their engagement with the diabetes research community as well as broader metabolic and infectious disease fields.

Recent papers authored or co-authored by Helen M. Colhoun include:

  • Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes, 2023, New England Journal of Medicine
  • Risk of hospital admission with coronavirus disease 2019 in healthcare workers and their households: nationwide linkage cohort study, 2020, BMJ
  • Risks of and risk factors for COVID-19 disease in people with diabetes: a cohort study of the total population of Scotland, 2020, The Lancet Diabetes & Endocrinology
  • Effect of dulaglutide on cognitive impairment in type 2 diabetes: an exploratory analysis of the REWIND trial, 2020, The Lancet Neurology
  • Semaglutide Effects on Cardiovascular Outcomes in People With Overweight or Obesity (SELECT) rationale and design, 2020, American Heart Journal

Helen M. Colhoun collaborates frequently with a number of researchers, including Paul McKeigue, Stuart J. McGurnaghan, Luke A. K. Blackbourn, David McAllister, and Sarah H. Wild. These partnerships contribute to a multidisciplinary approach within their fields of study and likely support the breadth of topics evident in their publication record.

Best Publications

  • Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial

    Helen M Colhoun;D John Betteridge;Paul N Durrington;Graham A Hitman

  • Efficacy and safety of LDL-lowering therapy among men and women: Meta-analysis of individual data from 174 000 participants in 27 randomised trials

    J Fulcher;R O'Connell;M Voysey

  • Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial

    Paul M Ridker;Jean G MacFadyen;Tom Thuren;Brendan M Everett

  • Problems of reporting genetic associations with complex outcomes.

    Helen M Colhoun;Paul M McKeigue;George Davey Smith

  • Association of LDL Cholesterol, Non–HDL Cholesterol, and Apolipoprotein B Levels With Risk of Cardiovascular Events Among Patients Treated With Statins: A Meta-analysis

    S. Matthijs Boekholdt;Benoit J. Arsenault;Samia Mora;Terje R. Pedersen

  • Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials

    Jane Armitage;Colin Baigent;Elizabeth Barnes;D John Betteridge

  • Very low levels of atherogenic lipoproteins and the risk for cardiovascular events: A meta-analysis of statin trials

    S. Matthijs Boekholdt;G. Kees Hovingh;Samia Mora;Benoit J. Arsenault

  • Estimated Life Expectancy in a Scottish Cohort With Type 1 Diabetes, 2008-2010

    Shona J. Livingstone;Daniel Levin;Helen C. Looker;Robert S. Lindsay

  • Use of insulin glargine and cancer incidence in Scotland: a study from the Scottish Diabetes Research Network Epidemiology Group

    H. M. Colhoun

  • Socio-economic status and blood pressure: an overview analysis

    Helen Colhoun;H. Hemingway;N. R. Poulter

  • Baseline and on-statin treatment lipoprotein(a) levels for prediction of cardiovascular events: individual patient-data meta-analysis of statin outcome trials

    Peter Willeit;Peter Willeit;Paul M Ridker;Paul J Nestel;John Simes

  • Efficacy and safety of alirocumab in high cardiovascular risk patients with inadequately controlled hypercholesterolaemia on maximally tolerated doses of statins: the ODYSSEY COMBO II randomized controlled trial

    Christopher P. Cannon;Bertrand Cariou;Dirk Blom;James M. McKenney

  • Common variants near ATM are associated with glycemic response to metformin in type 2 diabetes.

    K. Zhou;K. Zhou;C. Bellenguez;C.C.A. Spencer;A.J. Bennett

  • High risk of cardiovascular disease in patients with type 1 diabetes in the U.K.: a cohort study using the general practice research database.

    Sabita S. Soedamah-Muthu;John H. Fuller;Henrietta E. Mulnier;Veena S. Raleigh

  • Predictors of New-Onset Diabetes in Patients Treated With Atorvastatin Results From 3 Large Randomized Clinical Trials

    David D. Waters;Jennifer E. Ho;David A. DeMicco;Andrei Breazna

  • Blood pressure screening, management and control in England: results from the health survey for England 1994.

    Helen M. Colhoun;Wei Dong;Neil R. Poulter

  • Efficacy and safety of the proprotein convertase subtilisin/kexin type 9 inhibitor alirocumab among high cardiovascular risk patients on maximally tolerated statin therapy: The ODYSSEY COMBO I study.

    Dean J. Kereiakes;Jennifer G. Robinson;Christopher P. Cannon;Christelle Lorenzato

  • Risk of Cardiovascular Disease and Total Mortality in Adults with Type 1 Diabetes: Scottish Registry Linkage Study

    Shona J. Livingstone;Helen C. Looker;Eleanor J. Hothersall;Sarah H. Wild

  • Monotherapy with the PCSK9 inhibitor alirocumab versus ezetimibe in patients with hypercholesterolemia: Results of a 24 week, double-blind, randomized Phase 3 trial

    Eli M. Roth;Marja-Riitta Taskinen;Henry N. Ginsberg;John J.P. Kastelein

  • Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): Multicentre randomised placebo-controlled trial

    H.M. Colhoun;D.J. Betteridge;P.N. Durrington

Frequent Co-Authors

Paul McKeigue
Paul McKeigue University of Edinburgh
Naveed Sattar
Naveed Sattar University of Glasgow
Sarah H. Wild
Sarah H. Wild University of Edinburgh
Robert Lindsay
Robert Lindsay University of Glasgow
Colin N. A. Palmer
Colin N. A. Palmer University of Dundee
Graham A. Hitman
Graham A. Hitman Queen Mary University of London
Peter Rossing
Peter Rossing University of Copenhagen
Leif Groop
Leif Groop Lund University
Paul N. Durrington
Paul N. Durrington University of Manchester

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in the medical field, there are several flexible online programs that can open doors to rewarding careers. Exploring him programs is a smart way to build a strong foundation in managing patient data and health records—skills that are in demand across healthcare settings.

If you’re detail-oriented and interested in the technical side of healthcare, pursuing a medical coding certification can lead to job opportunities in medical billing, insurance, and administration.

Many nursing careers now offer remote study opportunities. For those looking for an advanced clinical role on a budget, the cheapest online fnp programs provide high-quality, affordable options for becoming a Family Nurse Practitioner.

Entry-level nurses can take advantage of online nursing programs to earn their qualifications without relocating.

These online degrees offer alternative routes into healthcare and can serve as stepping stones toward further study or specialized careers in medicine.

Best Scientists Citing Helen M. Colhoun

Trending Scientists

Recently Published Articles